Managed Account Advisors’s Pfizer PFE Stock Holding History

Managed Account Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$915M	Sell	28,776,605 -511,668	-2%	-$16.7M	0.76%	15
2015 Q1	$967M	Buy	29,288,273 +2,202,933	+8%	+$70M	0.85%	8
2014 Q4	$800M	Sell	27,085,340 -147,718	-0.5%	-$4.24M	0.79%	7
2014 Q3	$764M	Sell	27,233,058 -932,325	-3%	-$26.2M	0.85%	8
2014 Q2	$793M	Buy	28,165,383 +795,752	+3%	+$22.7M	0.95%	7
2014 Q1	$834M	Buy	27,369,631 +685,314	+3%	+$20.4M	1.09%	4
2013 Q4	$775M	Sell	26,684,317 -777,255	-3%	-$22.6M	1.04%	4
2013 Q3	$748M	Sell	27,461,572 -304,400	-1%	-$8.28M	1.1%	3
2013 Q2	$738M	Buy	+27,765,972	New	+$767M	1.14%	4

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Managed Account Advisors's PFE Position: Q2 2015 in Review

Managed Account Advisors reduced its Pfizer (PFE) stake by 1.7% in Q2 2015, selling an estimated $16.7M and leaving 28,776,605 shares worth $915M. The position accounts for 0.76% of the portfolio, ranked #15.

Managed Account Advisors first reported a position in PFE in Q2 2013 and has held it in 9 quarters since. The position peaked at $967M in Q1 2015. 1,886 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

Managed Account Advisors held 28,776,605 shares of Pfizer worth $915M as of Q2 2015.
Managed Account Advisors sold 511,668 Pfizer shares in Q2 2015, an estimated $16.7M.
Pfizer made up 0.76% of Managed Account Advisors's portfolio in Q2 2015, its #15 holding.
Managed Account Advisors first reported a position in Pfizer in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Pfizer position peaked at $967M in Q1 2015.
1,886 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.